Schossig, P.; Coskun, E.; Arsenic, R.; Horst, D.; Sehouli, J.; Bergmann, E.; Andresen, N.; Sigler, C.; Busse, A.; Keller, U.;
et al. Target Selection for T-Cell Therapy in Epithelial Ovarian Cancer: Systematic Prioritization of Self-Antigens. Int. J. Mol. Sci. 2023, 24, 2292.
https://doi.org/10.3390/ijms24032292
AMA Style
Schossig P, Coskun E, Arsenic R, Horst D, Sehouli J, Bergmann E, Andresen N, Sigler C, Busse A, Keller U,
et al. Target Selection for T-Cell Therapy in Epithelial Ovarian Cancer: Systematic Prioritization of Self-Antigens. International Journal of Molecular Sciences. 2023; 24(3):2292.
https://doi.org/10.3390/ijms24032292
Chicago/Turabian Style
Schossig, Paul, Ebru Coskun, Ruza Arsenic, David Horst, Jalid Sehouli, Eva Bergmann, Nadine Andresen, Christian Sigler, Antonia Busse, Ulrich Keller,
and et al. 2023. "Target Selection for T-Cell Therapy in Epithelial Ovarian Cancer: Systematic Prioritization of Self-Antigens" International Journal of Molecular Sciences 24, no. 3: 2292.
https://doi.org/10.3390/ijms24032292
APA Style
Schossig, P., Coskun, E., Arsenic, R., Horst, D., Sehouli, J., Bergmann, E., Andresen, N., Sigler, C., Busse, A., Keller, U., & Ochsenreither, S.
(2023). Target Selection for T-Cell Therapy in Epithelial Ovarian Cancer: Systematic Prioritization of Self-Antigens. International Journal of Molecular Sciences, 24(3), 2292.
https://doi.org/10.3390/ijms24032292